Synthetic cathinone poisoning from ingestion of drug-laced “instant coffee packets” in Taiwan
暂无分享,去创建一个
[1] Jih-Heng Li,et al. New psychoactive substances in Taiwan: challenges and strategies. , 2020, Current opinion in psychiatry.
[2] A. Riley,et al. Abuse potential and toxicity of the synthetic cathinones (i.e., “Bath salts”) , 2020, Neuroscience & Biobehavioral Reviews.
[3] Lian-Yu Chen,et al. Characteristics of analytically confirmed illicit substance-using patients in the Emergency Department. , 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.
[4] F. Schifano,et al. The clinical challenges of synthetic cathinones. , 2020, British journal of clinical pharmacology.
[5] Eunyoung Han,et al. Comparison of legislative management for new psychoactive substances control among Taiwan, South Korea, and Japan , 2020, The Kaohsiung journal of medical sciences.
[6] Cheng-Chung Fang,et al. Analytically confirmed 4-Methyl-N-ethylnorpentedrone (4-MEAP), a synthetic cathinone, in cases presenting to an emergency department , 2020, Clinical toxicology.
[7] Lian-Yu Chen. Psychiatric Profiles and Clinical Manifestations of Cathinone Users: Case Series of Analytically Confirmed Cathinone Use in Taiwan , 2019, Addiction & Addictive Disorders.
[8] A. Helander,et al. Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats , 2018, Clinical toxicology.
[9] E. London,et al. Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health , 2017, Front. Psychiatry.
[10] C. Rabe,et al. Synthetic cathinones in Southern Germany – characteristics of users, substance-patterns, co-ingestions, and complications , 2017, Clinical toxicology.
[11] Heesun Chung,et al. Comparison of illegal drug use pattern in Taiwan and Korea from 2006 to 2014 , 2016, Substance Abuse Treatment, Prevention, and Policy.
[12] T. Sakamoto,et al. A multicenter retrospective survey of poisoning after consumption of products containing novel psychoactive substances from 2013 to 2014 in Japan , 2016, The American journal of drug and alcohol abuse.
[13] A. Helander,et al. Intoxications involving MDPV in Sweden during 2010–2014: Results from the STRIDA project , 2015, Clinical toxicology.
[14] F. Busardò,et al. Mephedrone related fatalities: a review. , 2015, European review for medical and pharmacological sciences.
[15] J. Palamar. "Bath salt" use among a nationally representative sample of high school seniors in the United States. , 2015, The American journal on addictions.
[16] L. Orsolini,et al. Novel psychoactive substances of interest for psychiatry , 2015, World psychiatry : official journal of the World Psychiatric Association.
[17] M. Liechti. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling. , 2015, Swiss medical weekly.
[18] K. T. Wakabayashi,et al. Effects of Social Interaction and Warm Ambient Temperature on Brain Hyperthermia Induced by the Designer Drugs Methylone and MDPV , 2015, Neuropsychopharmacology.
[19] G. Hanson,et al. Bath salts and synthetic cathinones: an emerging designer drug phenomenon. , 2014, Life sciences.
[20] Wen-Ing Tsay,et al. The trend of drug abuse in Taiwan during the years 1999 to 2011 , 2013 .
[21] M. Casavant,et al. A 9-state analysis of designer stimulant, "bath salt," hospital visits reported to poison control centers. , 2013, Annals of emergency medicine.
[22] D. Touw,et al. Clinical Toxicology and Management of Intoxications With Synthetic Cathinones (“Bath Salts”) , 2013, Journal of pharmacy practice.
[23] M. Kane,et al. Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA , 2013, Journal of neurochemistry.
[24] F. Schifano,et al. Suspected and Confirmed Fatalities Associated With Mephedrone (4-Methylmethcathinone, “Meow Meow”) in the United Kingdom , 2012, Journal of clinical psychopharmacology.
[25] M. St-Onge,et al. Seizures and Hyponatremia Related to Ethcathinone and Methylone Poisoning , 2011, Journal of Medical Toxicology.
[26] J. Kelly,et al. Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. , 2011, Drug testing and analysis.
[27] Henry A Spiller,et al. Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States , 2011, Clinical toxicology.
[28] Mark Mitchelson,et al. Mephedrone toxicity in a Scottish emergency department , 2010, Emergency Medicine Journal.
[29] David W. Holt,et al. Case series of individuals with analytically confirmed acute mephedrone toxicity , 2010, Clinical toxicology.
[30] P. Dargan,et al. Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. , 2010, QJM : monthly journal of the Association of Physicians.
[31] J. O'Riordan,et al. A harmless high? , 2010, The Lancet.
[32] H. Persson,et al. Poisoning severity score. Grading of acute poisoning. , 1998, Journal of toxicology. Clinical toxicology.
[33] R. Glennon,et al. Methcathinone (“cat”): An enantiomeric potency comparison , 1995, Pharmacology Biochemistry and Behavior.
[34] M. Madion,et al. Sudden retinal manifestations of intranasal cocaine and methamphetamine abuse. , 1992, American journal of ophthalmology.